m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT03306
|
[1], [2] | |||
Histone modification
H3K18la
Epigenetic Regulator
METTL3
Direct
Enhancement
m6A modification
XIST
XIST
METTL3
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | X inactive specific transcript (XIST) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Histone modification (HistMod) | ||||
| Regulated Target | Histone H3 lysine 18 lactylation (H3K18la) | View Details | |||
| Downstream Gene | METTL3 | View Details | |||
| Crosstalk Relationship | Histone modification → m6A | Enhancement | |||
| Crosstalk Mechanism | Histone modification directly impacts m6A modification through modulating the level of m6A regulator | ||||
| Crosstalk Summary | LDHA knockdown-mediated inhibition of endogenous Histone H3 lysine 18 lactylation (H3K18la) suppressed osteogenic differentiation, a phenotype that was rescued by METTL3 overexpression. In conclusion, this study elucidates that histone lactylation-mediated upregulation of METTL3 promotes OLF progression through IGF2BP1-dependent m6A methylation of BMP2, providing novel insights into potential therapeutic strategies for OLF management. METTL3 regulates ossification of the posterior longitudinal ligament via the lncRNA X inactive specific transcript (XIST)/miR-302a-3p/USP8 axis. | ||||
| Responsed Disease | Ossification of spinal ligaments | ICD-11: FA83 | |||
In-vitro Model |
OLF-136
|
N.A. | Oryzias latipes | CVCL_3766 | |
References
: m6A sites